Geode Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RLMD
JHC
Geode Capital Management's RLMD Position: Q3 2026 in Review
Geode Capital Management reduced its Relmada Therapeutics (RLMD) stake by 5.3% in Q3 2026, selling an estimated $643K and leaving 2,361,437 shares worth $8.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2553.
Geode Capital Management first reported a position in RLMD in Q4 2019 and has held it in 28 quarters since. The position peaked at $18.2M in Q3 2022. 135 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.
- Geode Capital Management held 2,361,437 shares of Relmada Therapeutics worth $8.91M as of Q3 2026.
- Geode Capital Management sold 131,136 Relmada Therapeutics shares in Q3 2026, an estimated $643K.
- Relmada Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2553 holding.
- Geode Capital Management first reported a position in Relmada Therapeutics in Q4 2019 and has held it in 28 quarters since.
- Geode Capital Management's Relmada Therapeutics position peaked at $18.2M in Q3 2022.
- 135 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.